![Martin Alexander Krekling](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Alexander Krekling
Director/Board Member at Ostomycure AS
Profile
Martin Alexander Krekling is currently a Director at Ostomycure AS.
Previously, he was the Chief Executive Officer at Alertis Medical AS from 2009 to 2010.
He also worked as a Principal at Medtronic, Inc., St. Jude Medical LLC, The Institute of Cancer Research: Royal Cancer Hospital, and Neomed Management AS.
Mr. Krekling has a graduate degree from the University of Oslo and an MBA from BI Norwegian Business School.
Martin Alexander Krekling active positions
Companies | Position | Start |
---|---|---|
Ostomycure AS
![]() Ostomycure AS Miscellaneous Commercial ServicesCommercial Services Ostomycure AS develops solution for evacuating of fluids from the intestines. It include product called TIES is used for patients that have their colon or urinary bladder removed and thus need to get rid of the waste from the ileum in another fashion than the normal way. The company was founded by Bente Buveruds in 2003 and is headquartered in Oslo, Norway. | Director/Board Member | 06/05/2010 |
Former positions of Martin Alexander Krekling
Companies | Position | End |
---|---|---|
Alertis Medical AS
![]() Alertis Medical AS Medical DistributorsDistribution Services Alertis Medical AS was established in 2000 to develop and commercialize a unique technology for the early detection of critical conditions related to blood supply and respiration, addressing considerable unmet needs in medicine. The patented technology originates from the anesthesiologist Prof T. I. Tønnessen, MD, PhD, and the physicist P. Mirtaheri, PhD, at Rikshospitalet University Hospital, Oslo | President | 20/05/2010 |
Neomed Management AS
![]() Neomed Management AS Investment ManagersFinance Neomed Management AS is an investment firm based in Oslo. Founded in 1998, the firm specializes in private equity investments in the healthcare and life science sectors. Neomed advises several funds namely NeoMed I, II, III, IV and V. | Corporate Officer/Principal | - |
ST JUDE MEDICAL INC | Sales & Marketing | - |
The Institute of Cancer Research: Royal Cancer Hospital
![]() The Institute of Cancer Research: Royal Cancer Hospital Miscellaneous Commercial ServicesCommercial Services The Institute of Cancer Research: Royal Cancer Hospital operates as a cancer research institution. The company was founded in 1909 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Medtronic, Inc.
![]() Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
Training of Martin Alexander Krekling
University of Oslo | Graduate Degree |
BI Norwegian Business School | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 6 |
---|---|
Alertis Medical AS
![]() Alertis Medical AS Medical DistributorsDistribution Services Alertis Medical AS was established in 2000 to develop and commercialize a unique technology for the early detection of critical conditions related to blood supply and respiration, addressing considerable unmet needs in medicine. The patented technology originates from the anesthesiologist Prof T. I. Tønnessen, MD, PhD, and the physicist P. Mirtaheri, PhD, at Rikshospitalet University Hospital, Oslo | Distribution Services |
Medtronic, Inc.
![]() Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
The Institute of Cancer Research: Royal Cancer Hospital
![]() The Institute of Cancer Research: Royal Cancer Hospital Miscellaneous Commercial ServicesCommercial Services The Institute of Cancer Research: Royal Cancer Hospital operates as a cancer research institution. The company was founded in 1909 and is headquartered in London, the United Kingdom. | Commercial Services |
Ostomycure AS
![]() Ostomycure AS Miscellaneous Commercial ServicesCommercial Services Ostomycure AS develops solution for evacuating of fluids from the intestines. It include product called TIES is used for patients that have their colon or urinary bladder removed and thus need to get rid of the waste from the ileum in another fashion than the normal way. The company was founded by Bente Buveruds in 2003 and is headquartered in Oslo, Norway. | Commercial Services |
St. Jude Medical LLC
![]() St. Jude Medical LLC Medical SpecialtiesHealth Technology St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN. | Health Technology |
Neomed Management AS
![]() Neomed Management AS Investment ManagersFinance Neomed Management AS is an investment firm based in Oslo. Founded in 1998, the firm specializes in private equity investments in the healthcare and life science sectors. Neomed advises several funds namely NeoMed I, II, III, IV and V. | Finance |
- Stock Market
- Insiders
- Martin Alexander Krekling